Although PSA is a highly sensitive serum biomarker that has changed the management of prostate cancer, PSA testing is not perfect, since PSA levels increase with age and in other conditions, including BPH and prostatitis [29,30]. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.